Regulators narrowed the targeted age group for RSV vaccines Demand for RSV vaccines has fallen by up to two-thirds GSK maintains market lead despite reduced sales Some independent pharmacists said ...

GSK’s RSV vaccine is the only RSV vaccine with efficacy and safety data available through three full seasons, including in people at increased risk Safety and reactogenicity data are consistent ...

Fewer COVID-19 and RSV (respiratory syncytial virus) vaccines have been administered this year than were administered around the same time last year, according to a note from Jefferies analyst ...

KUTV — As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus (RSV ... about this new vaccine. What is Nirsevimab?

Flu vaccine uptake has consistently been higher than that for COVID-19 and RSV. However, flu vaccine uptake has waned in the wake of the pandemic, suggesting that many have become more skeptical ...

Some groups of Alberta seniors will be able to get the RSV vaccine, for free, starting later this month. The Alberta government announced Monday that the RSV vaccine, Abyrsvo, will be ...

Additional data from the phase 3 trial showed the vaccine came with a 94.1% effectiveness in preventing severe RSV when people got it during the first season and 64.2% a year later, the company ...

(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for now, excluding ...

In recent years, however, COVID-19 has not only stolen the public health spotlight but also eclipsed the development of the first RSV vaccine. Vaccine uptake may not be much better during the 2024 ...

phase III trial evaluating the efficacy and safety of a single dose of AREXVY(Respiratory Syncytial Virus Vaccine, Adjuvanted) against lower respiratory tract disease (LRTD) caused by respiratory ...